Latest Research | Long Covid
Latest long COVID research explores persistent symptoms, underlying mechanisms, and potential treatments. Studies reveal multi-system impacts, including cardiovascular, neurological, and respiratory issues. Researchers are investigating biomarkers for diagnosis and effective therapeutic interventions. Emerging data suggest the importance of vaccination in reducing long COVID risk. Ongoing trials aim to identify targeted therapies to alleviate prolonged symptoms and improve patient outcomes.
Long COVID caregivers bear a profound responsibility, navigating the complexities of an illness with uncertain trajectories. Their dedication extends beyond the traditional scope of caregiving, encompassing emotional support, advocacy, and often serving as a bridge between patients and healthcare systems. Their resilience in the face of ongoing challenges highlights the essential role they play in
Identification of CD8 T-cell dysfunction associated with symptoms in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and Long COVID and treatment with a nebulized antioxidant/anti-pathogen agent in a retrospective case series
Post-Covid breathing difficulties present complex challenges, but with a pragmatic approach, tailored interventions, and ongoing research, we're empowering patients to breathe easier and navigate the road to recovery with confidence
Understanding and addressing breathing patterns is key to managing symptoms, improving well-being, and enhancing quality of life
Elevated vascular transformation blood biomarkers in Long-COVID indicate angiogenesis as a key pathophysiological mechanism - Molecular Medicine
I’m doing the best I can to function and survive, even though I’m grieving the change in my health, ability to work, relationships, and future
Despite high vaccination rates, a substantial number of adults continued to experience persistent symptoms, impacting their daily lives and healthcare utilization
While efforts to address long COVID are underway, medical gaslighting remains a significant barrier to compassionate care. Educating healthcare professionals, raising awareness, and ensuring accessible information are crucial steps towards supporting long COVID patients and fostering inclusive, evidence-based care.
Identifying and validating diverse immune cells, cytokines, and plasma proteins as potential biomarkers for Long COVID is crucial for improving diagnosis and treatment, highlighting the need for further exploration of LC's complex etiologies through symptom clusters or sex stratification.
Large-scale phenotyping of patients with long COVID post-hospitalization reveals mechanistic subtypes of disease